AXLA - Axcella Health - Stock Price & Catalysts • BiopharmIQ

Enterprise Value

36.73M

Cash

8.884M

Avg Qtr Burn

-10.71M

Short % of Float

1.49%

Insider Ownership

15.78%

Institutional Own.

66.68%

Qtr Updated

06/30/23

Drug Pipeline

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.

Drug & Indication	Stage & Event	Catalyst Date
AXA1125 Details COVID-19	Phase 2/3 Initiation	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
AXA1125 Details Non-alcoholic steatohepatitis , Fatty liver disease, Liver disease	Failed Discontinued	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
AXA1665 Details Liver disease, Overt hepatic encephalopathy	Failed Discontinued	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.